This systematic review and meta-analysis aim to synthesize evidence from case reports on the iatrogenic transmission of amyloid proteins linked to CAA and AD.
Cerebral amyloid angiopathy (CAA) and Alzheimer’s disease (AD) are neurodegenerative disorders characterized by the abnormal deposition of amyloid proteins. Recent findings have raised concerns about the potential for iatrogenic transmission of these misfolded proteins through surgical and medical procedures.
Our search yielded 29 cases from all over the world. Patients were almost equally distributed into male or female (16 males and 13 females). The mean age at the time of intervention was 11.69±14.58 years, and the average age on presentation was 47.31±14.687 years, leaving an average latency period of 34.93±7.92 years. Most patients’ brains were contaminated by cadaveric dura mater graft (n=20, 68.97%), less frequently contaminated surgical instruments (n=8,27.59%) and RBC transfusion (n=2,6.9%). Diagnosis was made based on neuroimaging techniques in (n=10, 34.48%) patients, brain biopsy (n=9, 31.03%) or both (n=10, 34.48%). Amyloid-beta (Aβ) plaques ware observed in most patients (n=25, 86.2%). Tau tangles, neuritic plaques, prion like deposited were only found in 3 patients (10.34%), each. Lewy bodies were only reported in one case (3.45%).
This systematic review highlights the possibility for iatrogenic transmission of amyloid-beta (Aβ) plaques, particularly in patients who underwent neurosurgery and cadaveric dura mater grafts. Significant latency periods between intervention and clinical manifestation were noted. These findings emphasize the need for increased awareness and further research to prevent amyloid transmission through medical procedures.